Consort Med Plc ADR (CSRMY) 15.0000 $CSRMY
Atlas Completes Final Tranche of £16.9 Million Series B Fundraising
PR Newswire - Tue Apr 29, 1:00AM CDT
Atlas Genetics Ltd ("Atlas" or the "Company"
, the diagnostic company developing ultra-rapid decentralized and point-of-care (POC) tests for a range of infectious diseases, today announces that it has completed the final tranche of its £16.9m Series B financing.
The European Injectable Drug Delivery Technologies Expected to Reach $12.4 Billion by 2017 at a CAGR of 12.7% from 2012 To 2017
M2 - Wed Feb 26, 7:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/37kjcm/european) has announced the addition of the "European Injectable Drug Delivery - Market Forecasts to 2017" report to their offering. This research report categorizes the European injectable drug delivery technologies market into two segments, namely, Europe injectable drug delivery devices technologies and European injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (Germany, France, U.K., Spain, Italy, Russia and Rest of Europe (RoE)) to provide in-depth information on the European scenario. The European injectable drug delivery technologies market was valued at $6.8 billion in 2012, and is expected to reach $12.4 billion by 2017 at a CAGR of 12.7% from 2012 to 2017. Injectable drug delivery technologies are a combination of two major segments - devices and formulations. The European injectable drug delivery formulations technologies market is the largest segment in the market. This is due to a surge of biologics and the development of nanotechnologies. In addition, the market is segmented on the basis of its therapeutic applications. In the therapeutic field, hormonal disorders command the major segment due to the high demand of injectable in the treatment of diabetes. The growth of the injectable drug delivery technologies market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as Spain, Russia, Denmark, Ireland and others. However, factors such as needle-stick injuries and infections and development of alternate delivery methods are restraining the growth of the market. Companies Mentioned: - Alkermes, Inc - Bespak Europe, Ltd (Subsidiary Of Consort Medical, Plc) - Crossject - Gerresheimer AG - Haselmeier Gmbh - Injex Pharma Gmbh (Subsidiary Of Hns International, Inc) - Novo Nordisk A/S - Owen Mumford, Ltd - Sanofi - Schott AG - Vetter Pharma-Fertigung Gmbh & Co KG - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/37kjcm/european About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global And US Pharmaceutical Packaging Market For Manufacturing And Contract Packaging - 2013 Report
M2 - Mon Sep 16, 5:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6cdhl8/global_and_u_s) has announced the addition of the "Global And U.S. Pharmaceutical Packaging Market For Manufacturing And Contract Packaging - Industry Analysis, Size, Share, Growth, Trends & Forecast, 2012 - 2018" report to their offering. Development of new packaging solutions which provide product protection, quality, patient comfort and compliance, and security needs are expected to increase consumer consumption. This in turn is expected to drive the market for novel pharmaceutical packaging. In addition, increasing global drug counterfeit market and the subsequent development of anti-counterfeiting drug packaging technologies and products is expected to boost the demand for pharmaceutical packaging over the next few years. Furthermore, introduction and implementation of numerous stringent regulations and standards for pharmaceutical packaging by regulatory bodies such as Healthcare Compliance Packaging Council (HCPC), National Quality Forum (NQF) and Food and Drug Administration (FDA) is expected to fuel the growth of the market within the forecast period. However, availability of raw materials and volatility in the price of raw materials is expected to hamper the growth of the market. Moreover, complicated registration procedure of packaging is expected to be a key challenge in the growth of the market. North America dominated the pharmaceutical packaging market and accounted for over 30% of the market in 2011. The dominance of the North American region in the packaging market is primarily due to the large demand of pharmaceutical packaging in the U.S. and Canada. However, Asia Pacific is expected to show the fastest growth within the forecast period due to increased contract manufacturing activities, ageing population and growth of medical industry. Asia Pacific is expected to account for over 25% of the market by 2018. The pharmaceutical packaging market was highly fragmented in nature with the top five companies accounting for less than 25% of the market in 2011. Amcor, Becton Dickinson, Gerresheimer AG, MeadWestvaco and Rexam PLC were some of the leading manufacturers present in the market. Amcor was the largest company leading the pharmaceutical packaging market in 2011. Some other prominent manufacturers present in the market include West Pharmaceutical Services, Tear and Tape, 3M, Nypro, Schott, Consort Medical and Ypsomed. Key Topics Covered: 1 Preface 2 Executive Summary 3 Pharmaceutical Packaging : Industry Analysis 3.1 Introduction 3.2 Value chain analysis 3.3 Market drivers 3.4 Market restraints 3.5 Market opportunity 3.6 Porters five forces analysis 3.7 Pharmaceutical packaging market: Company market share analysis 3.8 Pharmaceutical packaging: Market attractiveness analysis 4 Pharmaceutical Packaging Market: Product Segment Analysis 4.1 Pharmaceutical packaging market: Product overview 4.2 Pharmaceutical packaging market, by product segment 5 Pharmaceutical Packaging Market: Regional Analysis 5.1 Pharmaceutical packaging market: Regional overview 5.2 North America 5.3 Europe 5.4 Asia Pacific 5.5 Rest of the World (RoW) 6 Company Profiles Companies Mentioned - Amcor - Catalent Pharma Solutions - Gerresheimer - MeadWestvaco - Rexam - Schott - West Pharmaceutical Services For more information visit http://www.researchandmarkets.com/research/6c...al_and_u_s About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
European Injectable Drug Delivery Market Report 2013-2017
M2 - Fri Sep 13, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sgx9cg/european) has announced the addition of the "European Injectable Drug Delivery - Market Forecasts to 2017" report to their offering. Injectable drug delivery technologies are a combination of two major segments - devices and formulations. The European injectable drug delivery formulations technologies market is the largest segment in the market. This is due to a surge of biologics and development of nanotechnologies. Based on product type, the injectable drug delivery devices technologies market is further categorized as conventional injection devices, self-injection devices, and others (microneedles, nanoneedles and blunt needle injections), while the injectable drug delivery formulation technologies market is categorized as conventional drug delivery formulations and novel drug delivery formulations. The conventional injection devices segment accounted for the largest share of the European injectable drug delivery technologies market in 2012. The market is also segmented on the basis of its therapeutic applications as auto immune diseases, hormonal imbalances, oncology, orphan/rare diseases (Hemophilia, Ribose-5-phosphate isomerase deficiency (RPI deficiency), Cystic Fibrosis, and Wilsons disease) and others (pain management, allergies, hepatitis C, and aesthetic treatment). Hormonal disorders commanded the largest share of the European injectable drug delivery technologies market in 2012. The European injectable drug delivery technologies market has witnessed challenging and dynamic market conditions (due to technological advancements and surge of biologics and biosimilars in pharmaceutical market) over the last five years. Newer products with better safety and efficacy contribute to the widespread adoption of injectable drug delivery technologiesby physicians and patients. However, factors such as needle-stick injuries and infections and development of alternate delivery methods (oral, nasal and topical) for injectable drugs are restraining the growth of the market. The key players in this market are Becton Dickinson & Co. (U.S.), Baxter International, Inc. (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Eli Lily & Co. (U.S.), Gerresheimer AG (Germany), Sanofi (France), West Pharmaceutical Services, Inc. (U.S.), Haselmeier GmbH (Germany), and Owen Mumford, Ltd. (U.K.). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 European Injectable Drug Delivery Devices Technologies Market 5 European Injectable Drug Delivery Formulation Technologies Market 6 European Injectable Drug Delivery Technologies Market, By Therapeutic Applications 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Overview, Financials, Products & Services, Strategy, & Developments - Alkermes, Inc - Bespak Europe, Ltd (Subsidiary Of Consort Medical, Plc) - Crossject - Gerresheimer AG - Haselmeier Gmbh - Injex Pharma Gmbh (Subsidiary Of Hns International, Inc) - Novo Nordisk A/S - Owen Mumford, Ltd - Sanofi - Schott AG - Vetter Pharma-Fertigung Gmbh & Co KG - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/sgx9cg/european
Injectable Drug Delivery 2013 Report
M2 - Thu Aug 29, 3:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rnpgd5/injectable_drug) has announced the addition of the Injectable Drug Delivery 2013 Report to their offering. Global Injectable Drug Delivery Technologies Market Forecast To Reach $43.3 Billion By 2017 At A CAGR Of 14.0% From 2012 To 2017 This research report categorizes the global injectable drug delivery technologies market into two segments:global injectable drug delivery devices technologies and global injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography to provide in-depth information on the global scenario. Market Highlights Growth drivers for the injectable drug delivery technologies market include product life cycle management, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes at global level and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as, India, and China. However, factors such as needle-stick injuries and infections, development of alternate delivery methods and product recalls are restraining the growth of the market. North America accounted for the largest market share of 41.3% of the global injectable drug delivery technologies market, followed by Europe (30.2%) in 2012. However, the region lags behind Europe in the self injection devices market. This is owing to low penetration rate of pen injectors in the US Asian and Latin American countries represent the fastest growing markets due to growing number of cancer and diabetes incidences, and improving patent compliance. Furthermore, stringent regulatory policies for approval of medical devices, and high competition in mature countries will compel the companies to focus on the emerging markets in Latin America and Asia. Key Topics Covered 1 Introduction 2 Executive Summary 3 Market Overview 3.1 Introduction 3.2 Market Segmentation 3.3 Market Dynamics 3.4 Market Share Analysis, By Major Players 4 Global Injectable Drug Delivery Devices Technologies Market 4.1 Introduction 4.2 Market Segmentation 4.3 Manufacturers Criteria For Selection Of An Injectable Device 4.4 Conventional Injectable Drug Delvery Devices 4.5 Self-Injection Devices 4.6 Others 5 Global Injectable Drug Delivery Formulation Technologies Market 5.1 Introduction 5.2 Conventional Drug Delivery 5.3 Novel Drug Delivery Formulation Technologies 6 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications 6.1 Introduction 6.2 Auto-Immune Diseases 6.3 Hormonal Disorders 6.4 Orphan/Rare Diseases 6.5 Oncology 6.6 Others 7 Geographic Analysis 8 Competitive Landscape 8.1 Introduction 8.2 Expansion 8.3 Agreements, Partnerships, Collaborations & Joint Ventures 8.4 New Product Launch 8.5 Mergers & Acquisitions 8.6 Other Developments 8.7 Approvals 9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* Companies Mentioned - Alkermes - Antares Pharma - Baxter International - Becton, Dickinson And Company - Bespak Europe, Ltd. (Subsidiary Of Consort Medical, Plc) - Crossject - Elcam Medical - Eli Lilly And Company - Gerresheimer - Haselmeier - Injex Pharma (Subsidiary Of Hns International) - Novo Nordisk - Owen Mumford - Sanofi - Schott - Shl Group - Terumo Corporation - Unilife Corporation - Vetter Pharma-Fertigung - West Pharmaceutical Services - Ypsomed Holding - Zogenix For more information visit http://www.researchandmarkets.com/research/rn...table_drug About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
European Injectable Drug Delivery Report 2013: Market Forecasts to 2017
M2 - Mon Jul 08, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9dn3fj/european) has announced the addition of the "European Injectable Drug Delivery - Market Forecasts to 2017" report to their offering. European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017 This research report categorizes the European injectable drug delivery technologies market into two segments, namely, Europe injectable drug delivery devices technologies and European injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (Germany, France, U.K., Spain, Italy, Russia and Rest of Europe (RoE)) to provide in-depth information on the European scenario. The
Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Fri Apr 12, 11:06AM CDT
Research and Markets has announced the addition of the "Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global
Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Wed Mar 27, 4:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v5s9t8/ireland_drug) has announced the addition of the "Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. Scope - Market size and company share data for Drug Delivery Devices market cate
Israel Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Tue Mar 19, 6:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lrkmsk/israel_drug) has announced the addition of the "Israel Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" report to their offering. This new report, Israel Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Israel Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline
Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Tue Mar 12, 11:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qq78sw/canada_drug) has announced the addition of GlobalData's new report "Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Canada Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials
South Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Fri Mar 08, 9:21AM CST
Research and Markets (http://www.researchandmarkets.com/research/x55r9s/south_africa_drug) has announced the addition of GlobalData's new report "South Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, South Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the South Africa Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with informatio
Middle East and Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Fri Mar 08, 6:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/9k86t3/middle_east_and) has announced the addition of GlobalData's new report "Middle East and Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, Middle East and Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Middle East and Africa Drug Delivery Devices market - South Africa, Saudi Arabia and Israel. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report
Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Fri Mar 08, 6:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/8flr2d/asiapacific_drug) has announced the addition of GlobalData's new report "Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report provides key market data on the Asia Pacific Drug Delivery Devices market - Japan, China, India, and Australia. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - 2011 compa
United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 8:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/ggj4tv/united_kingdom) has announced the addition of GlobalData's new report "United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the United Kingdom Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with informat
Mexico Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 7:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/fkjq86/mexico_drug) has announced the addition of GlobalData's new report "Mexico Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, Mexico Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Mexico Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials a
South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 6:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/7gl7rn/south_and_central) has announced the addition of GlobalData's new report "South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the South and Central America Drug Delivery Devices market - Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. Scope - Cou
North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 6:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/bhd7b3/north_america) has announced the addition of GlobalData's new report "North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the North America Drug Delivery Devices market - United States and Canada. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced
Atlas Completes Final Tranche of £16.9 Million Series B Fundraising
PR Newswire - Tue Apr 29, 1:00AM CDT
Atlas Genetics Ltd ("Atlas" or the "Company"
, the diagnostic company developing ultra-rapid decentralized and point-of-care (POC) tests for a range of infectious diseases, today announces that it has completed the final tranche of its £16.9m Series B financing. The European Injectable Drug Delivery Technologies Expected to Reach $12.4 Billion by 2017 at a CAGR of 12.7% from 2012 To 2017
M2 - Wed Feb 26, 7:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/37kjcm/european) has announced the addition of the "European Injectable Drug Delivery - Market Forecasts to 2017" report to their offering. This research report categorizes the European injectable drug delivery technologies market into two segments, namely, Europe injectable drug delivery devices technologies and European injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (Germany, France, U.K., Spain, Italy, Russia and Rest of Europe (RoE)) to provide in-depth information on the European scenario. The European injectable drug delivery technologies market was valued at $6.8 billion in 2012, and is expected to reach $12.4 billion by 2017 at a CAGR of 12.7% from 2012 to 2017. Injectable drug delivery technologies are a combination of two major segments - devices and formulations. The European injectable drug delivery formulations technologies market is the largest segment in the market. This is due to a surge of biologics and the development of nanotechnologies. In addition, the market is segmented on the basis of its therapeutic applications. In the therapeutic field, hormonal disorders command the major segment due to the high demand of injectable in the treatment of diabetes. The growth of the injectable drug delivery technologies market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as Spain, Russia, Denmark, Ireland and others. However, factors such as needle-stick injuries and infections and development of alternate delivery methods are restraining the growth of the market. Companies Mentioned: - Alkermes, Inc - Bespak Europe, Ltd (Subsidiary Of Consort Medical, Plc) - Crossject - Gerresheimer AG - Haselmeier Gmbh - Injex Pharma Gmbh (Subsidiary Of Hns International, Inc) - Novo Nordisk A/S - Owen Mumford, Ltd - Sanofi - Schott AG - Vetter Pharma-Fertigung Gmbh & Co KG - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/37kjcm/european About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global And US Pharmaceutical Packaging Market For Manufacturing And Contract Packaging - 2013 Report
M2 - Mon Sep 16, 5:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6cdhl8/global_and_u_s) has announced the addition of the "Global And U.S. Pharmaceutical Packaging Market For Manufacturing And Contract Packaging - Industry Analysis, Size, Share, Growth, Trends & Forecast, 2012 - 2018" report to their offering. Development of new packaging solutions which provide product protection, quality, patient comfort and compliance, and security needs are expected to increase consumer consumption. This in turn is expected to drive the market for novel pharmaceutical packaging. In addition, increasing global drug counterfeit market and the subsequent development of anti-counterfeiting drug packaging technologies and products is expected to boost the demand for pharmaceutical packaging over the next few years. Furthermore, introduction and implementation of numerous stringent regulations and standards for pharmaceutical packaging by regulatory bodies such as Healthcare Compliance Packaging Council (HCPC), National Quality Forum (NQF) and Food and Drug Administration (FDA) is expected to fuel the growth of the market within the forecast period. However, availability of raw materials and volatility in the price of raw materials is expected to hamper the growth of the market. Moreover, complicated registration procedure of packaging is expected to be a key challenge in the growth of the market. North America dominated the pharmaceutical packaging market and accounted for over 30% of the market in 2011. The dominance of the North American region in the packaging market is primarily due to the large demand of pharmaceutical packaging in the U.S. and Canada. However, Asia Pacific is expected to show the fastest growth within the forecast period due to increased contract manufacturing activities, ageing population and growth of medical industry. Asia Pacific is expected to account for over 25% of the market by 2018. The pharmaceutical packaging market was highly fragmented in nature with the top five companies accounting for less than 25% of the market in 2011. Amcor, Becton Dickinson, Gerresheimer AG, MeadWestvaco and Rexam PLC were some of the leading manufacturers present in the market. Amcor was the largest company leading the pharmaceutical packaging market in 2011. Some other prominent manufacturers present in the market include West Pharmaceutical Services, Tear and Tape, 3M, Nypro, Schott, Consort Medical and Ypsomed. Key Topics Covered: 1 Preface 2 Executive Summary 3 Pharmaceutical Packaging : Industry Analysis 3.1 Introduction 3.2 Value chain analysis 3.3 Market drivers 3.4 Market restraints 3.5 Market opportunity 3.6 Porters five forces analysis 3.7 Pharmaceutical packaging market: Company market share analysis 3.8 Pharmaceutical packaging: Market attractiveness analysis 4 Pharmaceutical Packaging Market: Product Segment Analysis 4.1 Pharmaceutical packaging market: Product overview 4.2 Pharmaceutical packaging market, by product segment 5 Pharmaceutical Packaging Market: Regional Analysis 5.1 Pharmaceutical packaging market: Regional overview 5.2 North America 5.3 Europe 5.4 Asia Pacific 5.5 Rest of the World (RoW) 6 Company Profiles Companies Mentioned - Amcor - Catalent Pharma Solutions - Gerresheimer - MeadWestvaco - Rexam - Schott - West Pharmaceutical Services For more information visit http://www.researchandmarkets.com/research/6c...al_and_u_s About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
European Injectable Drug Delivery Market Report 2013-2017
M2 - Fri Sep 13, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sgx9cg/european) has announced the addition of the "European Injectable Drug Delivery - Market Forecasts to 2017" report to their offering. Injectable drug delivery technologies are a combination of two major segments - devices and formulations. The European injectable drug delivery formulations technologies market is the largest segment in the market. This is due to a surge of biologics and development of nanotechnologies. Based on product type, the injectable drug delivery devices technologies market is further categorized as conventional injection devices, self-injection devices, and others (microneedles, nanoneedles and blunt needle injections), while the injectable drug delivery formulation technologies market is categorized as conventional drug delivery formulations and novel drug delivery formulations. The conventional injection devices segment accounted for the largest share of the European injectable drug delivery technologies market in 2012. The market is also segmented on the basis of its therapeutic applications as auto immune diseases, hormonal imbalances, oncology, orphan/rare diseases (Hemophilia, Ribose-5-phosphate isomerase deficiency (RPI deficiency), Cystic Fibrosis, and Wilsons disease) and others (pain management, allergies, hepatitis C, and aesthetic treatment). Hormonal disorders commanded the largest share of the European injectable drug delivery technologies market in 2012. The European injectable drug delivery technologies market has witnessed challenging and dynamic market conditions (due to technological advancements and surge of biologics and biosimilars in pharmaceutical market) over the last five years. Newer products with better safety and efficacy contribute to the widespread adoption of injectable drug delivery technologiesby physicians and patients. However, factors such as needle-stick injuries and infections and development of alternate delivery methods (oral, nasal and topical) for injectable drugs are restraining the growth of the market. The key players in this market are Becton Dickinson & Co. (U.S.), Baxter International, Inc. (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Eli Lily & Co. (U.S.), Gerresheimer AG (Germany), Sanofi (France), West Pharmaceutical Services, Inc. (U.S.), Haselmeier GmbH (Germany), and Owen Mumford, Ltd. (U.K.). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 European Injectable Drug Delivery Devices Technologies Market 5 European Injectable Drug Delivery Formulation Technologies Market 6 European Injectable Drug Delivery Technologies Market, By Therapeutic Applications 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Overview, Financials, Products & Services, Strategy, & Developments - Alkermes, Inc - Bespak Europe, Ltd (Subsidiary Of Consort Medical, Plc) - Crossject - Gerresheimer AG - Haselmeier Gmbh - Injex Pharma Gmbh (Subsidiary Of Hns International, Inc) - Novo Nordisk A/S - Owen Mumford, Ltd - Sanofi - Schott AG - Vetter Pharma-Fertigung Gmbh & Co KG - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/sgx9cg/european
Injectable Drug Delivery 2013 Report
M2 - Thu Aug 29, 3:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rnpgd5/injectable_drug) has announced the addition of the Injectable Drug Delivery 2013 Report to their offering. Global Injectable Drug Delivery Technologies Market Forecast To Reach $43.3 Billion By 2017 At A CAGR Of 14.0% From 2012 To 2017 This research report categorizes the global injectable drug delivery technologies market into two segments:global injectable drug delivery devices technologies and global injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography to provide in-depth information on the global scenario. Market Highlights Growth drivers for the injectable drug delivery technologies market include product life cycle management, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes at global level and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as, India, and China. However, factors such as needle-stick injuries and infections, development of alternate delivery methods and product recalls are restraining the growth of the market. North America accounted for the largest market share of 41.3% of the global injectable drug delivery technologies market, followed by Europe (30.2%) in 2012. However, the region lags behind Europe in the self injection devices market. This is owing to low penetration rate of pen injectors in the US Asian and Latin American countries represent the fastest growing markets due to growing number of cancer and diabetes incidences, and improving patent compliance. Furthermore, stringent regulatory policies for approval of medical devices, and high competition in mature countries will compel the companies to focus on the emerging markets in Latin America and Asia. Key Topics Covered 1 Introduction 2 Executive Summary 3 Market Overview 3.1 Introduction 3.2 Market Segmentation 3.3 Market Dynamics 3.4 Market Share Analysis, By Major Players 4 Global Injectable Drug Delivery Devices Technologies Market 4.1 Introduction 4.2 Market Segmentation 4.3 Manufacturers Criteria For Selection Of An Injectable Device 4.4 Conventional Injectable Drug Delvery Devices 4.5 Self-Injection Devices 4.6 Others 5 Global Injectable Drug Delivery Formulation Technologies Market 5.1 Introduction 5.2 Conventional Drug Delivery 5.3 Novel Drug Delivery Formulation Technologies 6 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications 6.1 Introduction 6.2 Auto-Immune Diseases 6.3 Hormonal Disorders 6.4 Orphan/Rare Diseases 6.5 Oncology 6.6 Others 7 Geographic Analysis 8 Competitive Landscape 8.1 Introduction 8.2 Expansion 8.3 Agreements, Partnerships, Collaborations & Joint Ventures 8.4 New Product Launch 8.5 Mergers & Acquisitions 8.6 Other Developments 8.7 Approvals 9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* Companies Mentioned - Alkermes - Antares Pharma - Baxter International - Becton, Dickinson And Company - Bespak Europe, Ltd. (Subsidiary Of Consort Medical, Plc) - Crossject - Elcam Medical - Eli Lilly And Company - Gerresheimer - Haselmeier - Injex Pharma (Subsidiary Of Hns International) - Novo Nordisk - Owen Mumford - Sanofi - Schott - Shl Group - Terumo Corporation - Unilife Corporation - Vetter Pharma-Fertigung - West Pharmaceutical Services - Ypsomed Holding - Zogenix For more information visit http://www.researchandmarkets.com/research/rn...table_drug About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
European Injectable Drug Delivery Report 2013: Market Forecasts to 2017
M2 - Mon Jul 08, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9dn3fj/european) has announced the addition of the "European Injectable Drug Delivery - Market Forecasts to 2017" report to their offering. European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017 This research report categorizes the European injectable drug delivery technologies market into two segments, namely, Europe injectable drug delivery devices technologies and European injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (Germany, France, U.K., Spain, Italy, Russia and Rest of Europe (RoE)) to provide in-depth information on the European scenario. The
Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Fri Apr 12, 11:06AM CDT
Research and Markets has announced the addition of the "Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global
Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Wed Mar 27, 4:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v5s9t8/ireland_drug) has announced the addition of the "Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. Scope - Market size and company share data for Drug Delivery Devices market cate
Israel Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Tue Mar 19, 6:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lrkmsk/israel_drug) has announced the addition of the "Israel Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" report to their offering. This new report, Israel Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Israel Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline
Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Tue Mar 12, 11:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qq78sw/canada_drug) has announced the addition of GlobalData's new report "Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Canada Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials
South Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Fri Mar 08, 9:21AM CST
Research and Markets (http://www.researchandmarkets.com/research/x55r9s/south_africa_drug) has announced the addition of GlobalData's new report "South Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, South Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the South Africa Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with informatio
Middle East and Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Fri Mar 08, 6:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/9k86t3/middle_east_and) has announced the addition of GlobalData's new report "Middle East and Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, Middle East and Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Middle East and Africa Drug Delivery Devices market - South Africa, Saudi Arabia and Israel. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report
Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Fri Mar 08, 6:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/8flr2d/asiapacific_drug) has announced the addition of GlobalData's new report "Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report provides key market data on the Asia Pacific Drug Delivery Devices market - Japan, China, India, and Australia. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - 2011 compa
United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 8:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/ggj4tv/united_kingdom) has announced the addition of GlobalData's new report "United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the United Kingdom Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with informat
Mexico Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 7:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/fkjq86/mexico_drug) has announced the addition of GlobalData's new report "Mexico Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, Mexico Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Mexico Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials a
South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 6:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/7gl7rn/south_and_central) has announced the addition of GlobalData's new report "South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the South and Central America Drug Delivery Devices market - Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. Scope - Cou
North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 6:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/bhd7b3/north_america) has announced the addition of GlobalData's new report "North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the North America Drug Delivery Devices market - United States and Canada. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced
